Your browser doesn't support javascript.
loading
Elevated plasma sTIM-3 levels in patients with severe COVID-19.
Ueland, Thor; Heggelund, Lars; Lind, Andreas; Holten, Aleksander R; Tonby, Kristian; Michelsen, Annika E; Jenum, Synne; Jørgensen, Marthe J; Barratt-Due, Andreas; Skeie, Linda G; Nordøy, Ingvild; Aanensen Fraz, Mai Sasaki; Quist-Paulsen E, Else; Pischke, Søren E; Johal, Simreen K; Hesstvedt, Liv; Bogen, Mette; Fevang, Børre; Halvorsen, Bente; Müller, Fredrik; Bekken, Gry Kloumann; Mollnes, Tom E; Dudman, Susanne; Aukrust, Pål; Dyrhol-Riise, Anne M; Holter, Jan C.
Afiliación
  • Ueland T; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Faculty of Health Sciences, K.G. Jebsen TREC, University of Tromsø, Tromsø, Norway. Electronic address: thor.ueland@medisin.uio.no.
  • Heggelund L; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway; Department of Internal Medicine, Drammen Hospital, Drammen, Norway.
  • Lind A; Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  • Holten AR; Division of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
  • Tonby K; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Michelsen AE; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Jenum S; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Jørgensen MJ; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Barratt-Due A; Division of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
  • Skeie LG; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Nordøy I; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway; Research Laboratory, Nordland Hospital, Bodø, Norway.
  • Aanensen Fraz MS; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
  • Quist-Paulsen E E; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  • Pischke SE; Division of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway; Department of Immunology, University of Oslo, Oslo, Norway.
  • Johal SK; Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  • Hesstvedt L; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Bogen M; Department of Laboratory Medicine, Vestre Viken Hospital Trust, Drammen, Norway.
  • Fevang B; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Halvorsen B; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Müller F; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  • Bekken GK; Department of Internal Medicine, Drammen Hospital, Drammen, Norway.
  • Mollnes TE; Faculty of Health Sciences, K.G. Jebsen TREC, University of Tromsø, Tromsø, Norway; Department of Immunology, University of Oslo, Oslo, Norway; Research Laboratory, Nordland Hospital, Bodø, Norway; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim,
  • Dudman S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Microbiology, Oslo University Hospital, Oslo, Norway.
  • Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Faculty of Health Sciences, K.G. Jebsen TREC, University of Tromsø, Tromsø, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo Universi
  • Dyrhol-Riise AM; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Holter JC; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Microbiology, Oslo University Hospital, Oslo, Norway.
J Allergy Clin Immunol ; 147(1): 92-98, 2021 01.
Article en En | MEDLINE | ID: mdl-32971109
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptor 2 Celular del Virus de la Hepatitis A / SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptor 2 Celular del Virus de la Hepatitis A / SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Año: 2021 Tipo del documento: Article